Nurse Practitioner · Houston, TX
NPI
1326417171
Since 2015
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
4
Medicare group memberships
Hospitals
0
Hospital affiliations
1201 Fannin St Ste 262
Houston, TX, 77002
Phone (866) 849-0692
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$643K
2,355 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Tamara Lawry prescribed most often to Medicare patients was Jardiance (Empagliflozin), with 244 prescriptions and refills. In total Tamara Lawry wrote 2,355 Medicare prescriptions that cost $643K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-30.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Jardiance Empagliflozin | 244 | 314 | 85 | $177K |
| Glipizide Generic | 231 | 514 | 101 | $2,504 |
| Glimepiride Generic | 181 | 415 | 61 | $3,302 |
| Novolin 70-30 Flexpen Insulin Nph Hum/Reg Insulin Hm | 121 | 168 | 48 | $13K |
| Ozempic Semaglutide | 116 | 145 | 42 | $121K |
| Fenofibrate Fenofibrate Nanocrystallized | 116 | 220 | 44 | $2,225 |
| Soliqua 100-33 Insulin Glargine/Lixisenatide | 82 | 127 | 35 | $70K |
| Losartan Potassium Generic | 78 | 196 | 37 | $1,841 |
| Glipizide Er Glipizide | 62 | 149 | 24 | $1,593 |
| Amlodipine Besylate Generic | 62 | 139 | 31 | $636 |
| Atorvastatin Calcium Generic | 58 | 165 | 28 | $1,734 |
| Metformin Hcl Generic | 58 | 126 | 22 | $279 |
| Fenofibrate Generic | 54 | 136 | 21 | $1,308 |
| Rosuvastatin Calcium Generic | 54 | 153 | 25 | $3,041 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 52 | 162 | 30 | $5,257 |
Brand drugs: 917 claims; generic drugs: 1,338 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Tamara Lawry were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.